GSK to acquire Affinivax in $3.3 billion deal

GlaxoSmithKline plc (GSK) announced on Tuesday that it will acquire clinical-stage biopharmaceutical company Affinivax, Inc. “for a $2.1 billion upfront payment and up to $1.2 billion in potential dev…